Avenue Therapeutics News

Avenue Therapeutics | PRE 14C: Preliminary information statement not related to a contested matter or merger/acquisition

Mar 8 16:38 ET

Avenue Therapeutics | CORRESP: CORRESP

Jan 30 11:45 ET

Avenue Therapeutics | UPLOAD: Others

Jan 29 11:45 ET

Avenue Therapeutics | PRE 14C: Preliminary information statement not related to a contested matter or merger/acquisition

Jan 17 00:00 ET

Avenue Therapeutics | CORRESP: CORRESP

Oct 30, 2023 15:53 ET

Avenue Therapeutics | CORRESP: CORRESP

Oct 30, 2023 15:52 ET

Avenue Therapeutics | CORRESP: CORRESP

Oct 27, 2023 17:28 ET

Avenue Therapeutics | CORRESP: CORRESP

Oct 27, 2023 17:28 ET

Avenue Therapeutics | CORRESP: CORRESP

Oct 24, 2023 17:11 ET

Avenue Therapeutics | CORRESP: CORRESP

Oct 24, 2023 17:10 ET

Avenue Therapeutics | UPLOAD: Others

Sep 21, 2023 14:30 ET

Avenue Therapeutics | CORRESP: CORRESP

Jun 23, 2023 12:41 ET

Avenue Therapeutics | UPLOAD: Others

Jun 22, 2023 10:30 ET

Avenue Therapeutics | CORRESP: CORRESP

May 1, 2023 16:05 ET

Avenue Therapeutics | UPLOAD: Others

Apr 17, 2023 15:30 ET

Avenue Therapeutics | CORRESP: CORRESP

Oct 5, 2022 11:44 ET

Avenue Therapeutics | CORRESP: CORRESP

Oct 5, 2022 11:42 ET

Avenue Therapeutics | UPLOAD: Others

Sep 2, 2022 11:30 ET

Avenue Therapeutics | PRE 14C: Preliminary information statement not related to a contested matter or merger/acquisition

Aug 10, 2022 17:15 ET

Avenue Therapeutics | CORRESP: CORRESP

Dec 9, 2021 08:00 ET